Document is current
Any future updates will be listed below
-
Authors
Lyu, Jiankun
Irwin, John J. https://orcid.org/0000-0002-1195-6417
Shoichet, Brian K. https://orcid.org/0000-0002-6098-7367
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM133836, R35GM122481)
- License Information
-
More Information
Article History
Received: 1 August 2022
Accepted: 22 November 2022
First Online: 16 January 2023
Competing interests
: B.K.S. is a co-founder of BlueDolphin, LLC, a molecular docking contract research organization, Epiodyne and Deep Apple Therapeutics, Inc., both drug discovery companies, has recently consulted for Umbra, Abbvie and Dice Therapeutics, and is on the Scientific Advisory Board of Schrödinger. J.J.I. co-founded Deep Apple Therapeutics, Inc. and BlueDolphin, LLC. J.L. declares no competing interests.
